Key facts
- Developer and manufacture of long-term implant system, speech conversion platform and other medical equipment designed for the treatment of speech disorders.
- It has raised $10.0M; the latest was Accelerator/Incubator ($10K) in May 2024.
- Notable investors include MedTech Innovator, Qualcomm Innovate in Taiwan Challenge, Taiwania Capital, TransPacific Venture Partners.
- Status: Privately Held (backing).
Free account
More of APrevent Medical with a free account
- ·Watch APrevent Medical: the Monday email on marks, rounds and moves
Create free account
No card required
Funding rounds
No rounds on record
No funding rounds for APrevent Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Pro members can request priority coverage with a 48-hour turnaround.
About APrevent Medical
Developer and manufacture of long-term implant system, speech conversion platform and other medical equipment designed for the treatment of speech disorders. The company offers minimally invasive and innovative ENT implant and Software-as-a-Service (SaaS) technologies for voice & speech disorders, enabling patients to improve voice and communication.
- Sector
- Healthcare
- HQ
- Taipei, Taiwan
- Founded
- 2013
- Website
- apreventmed.com/en
- Ownership
- Privately Held (backing)
Valuation — not yet priced
APrevent Medical doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.